DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment

NCT02504229 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

BIOLOGICAL: autologous dendritic cells co-cultured with cytokine-induced killer cells
DRUG: Gimeracil and Oteracil Porassium Capsules
DRUG: Oxaliplatin

Sponsor

Beijing Biohealthcare Biotechnology Co.,Ltd